| Code | Name | Deposits | Targets | Ligand Type |
|---|---|---|---|---|
| 0JN | 1-tert-butyl-3-(naphthalen-1-ylmethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine | 1 | 1 | crystallization |
| 2NV | 3,6,9,12,15-pentaoxaoctadecan-17-amine | 1 | 1 | crystallization |
| 30N | (3r,5s,9r)-1-[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-tr ihydroxy-8,8-dimethyl-10,14-dioxo-2,4,6-trioxa-11,15-di aza-3,5-diphosphaheptadecane-17-sulfinic acid 3,5-dioxi de (non-preferred name) | 1 | 1 | biological |
| 3D1 | (2r,3s,5r)-5-(6-amino-9h-purin-9-yl)-tetrahydro-2-(hydr oxymethyl)furan-3-ol | 1 | 1 | biological |
| 0RV | (2s)-2-[(1s,2r)-1-carboxy-2-hydroxypropyl]-4-{[(3s,5s)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-2h-pyrrole-5-carboxylic acid | 1 | 1 | biological |
| 3GR | glyceraldehyde | 1 | 1 | other |
| 3HB | 1 | 1 | biological | |
| 537 | 2,6-dihydroanthra/1,9-cd/pyrazol-6-one | 1 | 1 | crystallization |
| 178 | 1 | 1 | biological | |
| 5WP | 1 | 1 | biological | |
| 5WQ | 1 | 1 | biological | |
| 649 | 5'-o-[(11-phenoxyundecanoyl)sulfamoyl]adenosine | 1 | 1 | biological |
| 13P | 1,3-dihydroxyacetonephosphate | 1 | 1 | other |
| 6L0 | 1 | 1 | biological | |
| 6PC | 1 | 1 | biological | |
| 6PG | 6-phosphogluconic acid | 1 | 1 | biological |
| 221 | 1 | 1 | crystallization | |
| 7CY | (1r,2s,3r,5r)-3-(6-amino-9h-purin-9-yl)-5-(hydroxymethy l)cyclopentane-1,2-diol | 1 | 1 | biological |
| 7PE | 2-(2-(2-(2-(2-(2-ethoxyethoxy)ethoxy)ethoxy)ethoxy)etho xy)ethanol | 1 | 1 | crystallization |
| ALY | 1 | 1 | modified residue |